Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity
Benny Zhitomirsky(Broad Institute), Yehuda G. Assaraf(Technion – Israel Institute of Technology)
Cited by 110
Related Papers
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
|Drug Resistance Updates|2019|198
Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest
|Cell Death and Disease|2014|64